tiprankstipranks
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
US Market
Holding GEHC?
Track your performance easily

GE Healthcare Technologies Inc (GEHC) Earnings Date & Reports

1,146 Followers

Earnings Data

Report Date
Feb 13, 2025
Before Open Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$1.26
Last Year’s EPS
$1.18
Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Oct 30, 2024
|
% Change Since: -7.46%
|
Next Earnings Date:Feb 13, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with strong performance in the U.S. market, significant growth in pharmaceutical diagnostics, and improvements in backlog and margins. However, the company faced challenges due to market headwinds in China, impacting overall sales growth. The emphasis on innovation and partnerships, along with improved cash flow and margin performance, provides a positive outlook despite the challenges in specific segments and regions.
Company Guidance
During the GE HealthCare Q3 2024 earnings call, several key metrics and guidance points were discussed. The company reported a 1% organic revenue growth, which aligned with their expectations, and noted strong performance in the U.S. market across all segments. Excluding China, reported sales growth was approximately 5% and orders growth was 4%. The backlog increased to $19.6 billion, up $1.2 billion year-over-year. Adjusted EBIT margin improved to 16.3%, up 90 basis points compared to the previous year, and adjusted EPS increased by 15% year-over-year to $1.14. The company anticipates full-year organic revenue growth towards the lower end of the 1% to 2% range due to ongoing softness in the China market. GE HealthCare raised the low end of their full-year adjusted EBIT margin guidance to 15.8% to 16%, reflecting a 70 to 90 basis point expansion, and adjusted EPS guidance to $4.25 to $4.35 per share, indicating 8% to 11% growth. They continue to expect free cash flow for the year to be approximately $1.8 billion.
Strong U.S. Performance
The U.S. market showed strong performance across all segments, with significant growth in pharmaceutical diagnostics, multiyear enterprise deals in imaging products, and solid PDx revenue performance.
Growth in Backlog
The company reported a healthy backlog of $19.6 billion, up $1.2 billion year-over-year, driven primarily by services, with a company book-to-bill ratio of 1.04x.
Adjusted EBIT Margin Increase
The adjusted EBIT margin increased by 90 basis points year-over-year to 16.3%, and the adjusted EPS was up by 15% year-over-year.
Pharmaceutical Diagnostics Growth
Pharmaceutical Diagnostics (PDx) segment delivered 7% year-over-year organic growth with an EBIT margin of approximately 31%.
Free Cash Flow Improvement
The company generated free cash flow of $651 million, up $81 million year-over-year, with improvements in working capital management efficiency.
Innovation and Partnerships
GE HealthCare secured FDA clearance for a new theranostics software tool and established a center of excellence in Germany, leading a $28 million initiative to expand its use.
---

GE Healthcare Technologies Inc (GEHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GEHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 13, 20252024 (Q4)
1.26 / -
1.18
Oct 30, 20242024 (Q3)
1.05 / 1.14
0.9915.15% (+0.15)
Jul 31, 20242024 (Q2)
0.98 / 1.00
0.928.70% (+0.08)
Apr 30, 20242024 (Q1)
0.91 / 0.90
0.855.88% (+0.05)
Feb 06, 20242023 (Q4)
1.07 / 1.18
1.31-9.92% (-0.13)
Oct 31, 20232023 (Q3)
0.90 / 0.99
0.8812.50% (+0.11)
Jul 25, 20232023 (Q2)
0.87 / 0.92
1.068-13.86% (-0.15)
Apr 25, 20232023 (Q1)
0.79 / 0.85
0.857-0.82% (>-0.01)
Jan 30, 20232022 (Q4)
- / 1.31
1.245.65% (+0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

GEHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 30, 2024$85.27$87.20+2.26%
Jul 31, 2024$82.62$84.60+2.40%
Apr 30, 2024$88.88$76.19-14.28%
Feb 06, 2024$73.33$81.87+11.65%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does GE Healthcare Technologies Inc (GEHC) report earnings?
GE Healthcare Technologies Inc (GEHC) is schdueled to report earning on Feb 13, 2025, Before Open Not Confirmed.
    What is GE Healthcare Technologies Inc (GEHC) earnings time?
    GE Healthcare Technologies Inc (GEHC) earnings time is at Feb 13, 2025, Before Open Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is GEHC EPS forecast?
          GEHC EPS forecast for the fiscal quarter 2024 (Q4) is $1.26.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis